|
[1] MELENHORST MC,SCHEFFER HJ,VROOMEN LG,et al.Percutaneous irreversible electroporation of unresectable hilar cholangiocarcinoma(klatskin tumor):A case report[J]. Cardiovasc Intervent Radiol,2016,39(1):117-121.
|
|
[2] MADHUSUDHAN KS,GAMANAGATTI S,GUPTA AK. Imaging and interventions in hilar cholangiocarcinoma:A review[J]. World J Radiol,2015,7(2):28-44.
|
|
[3] GRUNNET M1,MAU-SORENSEN M. Serum tumor markers in bile duct cancer—a review[J]. Biomarkers,2014,19(6):437-443.
|
|
[4] SOARES KC,KAMEL I,COSGROVE DP,et al. Hilar cholangiocarcinoma:Diagnosis, treatment options, and management[J]. Hepatobiliary Surg Nutr,2014,3(1):18-34.
|
|
[5] DONG JH,FENG XB. Treatment of hilar cholangiocarcinoma in the era of precision surgery[J]. Chin J Dig Surg,2019,18(4):307-310.(in Chinese)董家鸿，冯晓彬．精准外科时代的肝门部胆管癌治疗[J]．中华消化外科杂志，2019,18(4):307-310.
|
|
[6] BISMUTH H,CORLETTE MB. Intrahepatic cholangioenteric anastomosis in carcinoma of the hilus of the liver[J]. Surg Gynecol Obstet,1975,140(2):170-178.
|
|
[7] BISMUTH H,NAKACHE R,DIAMOND T. Management strategies in resection for hilar cholangiocarcinoma[J]. Ann Surg,1992,215(1):31-38.
|
|
[8] WANG K,HE ZY,LIU YF,et al. The value of 256-MDCT three-dimensional image analysis in the treatment of hepatic hilar cholangiocarcinoma of Bismuth-Corlette III-type[J].Clin J Med Offic,2018,46(8):858-861.(in Chinese)王坤，何忠野，刘也夫，等．三维影像分析在Bismuth-Corlette III型肝门部胆管癌治疗中应用价值[J]．临床军医杂志，2018,46(8):858-861.
|
|
[9] TSAO JI,NIMURA Y,KAMIYA J,et al. Management of hilar cholangiocarcinoma:Comparison of an American and a Japanese experience[J]. Ann Surg,2000,232(2):166-174.
|
|
[10] CHENG QB,YI B,WANG JH,et al. Resection with total caudate lobectomy confers survival benefit in hilar cholangiocarcinoma of Bismuth type III and IV[J]. Eur J Surg Oncol,2012,38(12):1197-1203.
|
|
[11] REA DJ,HEIMBACH JK,ROSEN CB,et al. Liver transplantation with neoadjuvant chemoradiation is more effective than resection for hilar cholangiocarcinoma[J]. Ann Surg,2005,242(3):451-458.
|
|
[12] DARWISH MURAD S,KIM WR,HARNOIS DM,et al. Efficacy of neoadjuvant chemoradiation,followed by liver transplantation,for perihilar cholangiocarcinoma at 12 US centers[J].Gastroenterology,2012,143(1):88-98.
|
|
[13] BURKE EC,JARNAGIN WR,HOCHWALD SN,et al. Hilar Cholangiocarcinoma:Patterns of spread,the importance of hepatic resection for curative operation,and a presurgical clinical staging system[J]. Ann Surg,1998,228(3):385-394.
|
|
[14] JARNAGIN WR,FONG Y,DEMATTEO RP,et al. Staging,resectability,and outcome in 225 patients with hilar cholangiocarcinoma[J]. Ann Surg,2001,234(4):507-517.
|
|
[15] HEMMING AW,REED AI,FUJITA S,et al. Surgical management of hilar cholangiocarcinoma[J]. Ann Surg,2005,241(5):693-699.
|
|
[16] ITO F,AGNI R,RETTAMMEL RJ,et al. Resection of hilar cholangiocarcinoma:Concomitant liver resection decreases hepatic recurrence[J]. Ann Surg,2008,248(2):273-279.
|
|
[17] AMIN MB,EDGE SB,GREENE FL,et al. AJCC Cancer Staging Manual[M]. 8th ed. New York:Springer,2017.
|
|
[18] EDGE SB,BYRD DR,COMPYON CC,et al. AJCC Cancer Staging Manual[M]. 7th ed. New York:Springer,2010.
|
|
[19] EBATA T,KOSUGE T,HIRANO S,et al. Proposal to modify the International Union Against Cancer staging system for perihilar cholangiocarcinomas[J]. Br J Surg,2014,101(2):79-88.
|
|
[20] AOBA T,EBATA T,YOKOYAMA Y,et al. Assessment of nodal status for perihilar cholangiocarcinoma:Location,number,or ratio of involved nodes[J]. Ann Surg,2013,257(4):718-725.
|
|
[21] MAO K,LIU J,SUN J,et al. Patterns and prognostic value of lymph node dissection for resected perihilar cholangiocarcinoma[J]. J Gastroenterol Hepatol,2016,31(2):417-426.
|
|
[22] SHIMIZU H,KIMURA F,YOSHIDOME H,et al. Aggressive surgical approach for stage IV gallbladder carcinoma based on Japanese Society of Biliary Surgery classification[J]. J Hepatobiliary Pancreat Surg,2007,14(4):358-365.
|
|
[23] SASAKI R,MURATA S,ODA T,et al. Evaluation of UICCTNM and JSBS staging systems for surgical patients with extrahepatic cholangiocarcinoma[J]. Langenbecks Arch Surg,2010,395(6):615-623.
|
|
[24] MIYAKAWA S,IAHIHARA S,HORIGUCHI A,et al. Biliary tract cancer treatment:5,584 results from the Biliary Tract Cancer Statistics Registry from 1998 to 2004 in Japan[J]. J Hepatobiliary Pancreat Surg,2009,16(1):1-7.
|
|
[25] GAZZANIGA GM,FAGGIONI A,FILAURO M. Surgical treatment of proximal bile duct tumors[J]. Int Surg,1985,70(1):45-48.
|
|
[26] GAZZANIGA GM,FILAURO M,BAGAROLO C,et al. Surgery for hilar cholangiocarcinoma:An Italian experience[J]. J Hepatobiliary Pancreat Surg,2000,7(2):122-127.
|
|
[27] DEOLIVEIRA ML,SCHULICK RD,NIMURA Y,et al. New staging system and a registry for perihilar cholangiocarcinoma[J]. Hepatology,2011,53(4):1363-1371.
|
|
[28] CHAITEERAKIJ R,HARMSEN WS,MARRERO CR,et al. A new clinically based staging system for perihilar cholangiocarcinoma[J]. Am J Gastroenterol,2014,109(12):1881-1890.
|
|
[29] SUN XZ. Prognosis influence for hilar cholangiocarcinoma and comparisons of prognosis values of Mayo staging and TMN staging systems[D]. Qingdao:Qingdao University,2017.(in Chinese)孙晓智．梅奥分期和TNM分期对肝门胆管癌预后的评估价值及其对比研究[D]．青岛:青岛大学，2017.
|
|
[30] BLECHACZ BR,SANCHEZ W,GORES GJ. A conceptual proposal for staging ductal cholangiocarcinoma[J]. Curr Opin Gastroenterol,2009,25(3):238-239.
|
|
[31] WU XL. The clinical value of Blechacz’s staging system in the preoperative assessment of hilar cholangiocarcinoma[D].Wuhan:Huazhong University of Science and Technology,2015.(in Chinese)吴晓龙．Blechacz分期在肝门部胆管癌术前评估中的应用价值[D]．武汉:华中科技大学，2015.
|
DownLoad: